Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Product of the Week Previous | All Articles This Week | Next
This article originally posted 08 February, 2012 and appeared in  Medication, Issue 612

Janumet XR- Once Daily Dosage

Janumet XR- Once Daily Dosage

JanumetThe FDA approved JANUMET® XR (sitagliptin and metformin hydrochloride (HCl) extended-release) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of JANUVIA® (sitagliptin), with extended-release metformin. JANUMET XR provides a convenient once-daily treatment option (See this week's Item #3.)
Advertisement

Related Articles

New Obesity Drug Now Available Glyburide Shows Promise as a Treatment for Gestational Diabetes Core Defects of Type 2 Diabetes, Part 4 of 4
Advertisement

 

Bookmark and Share | Print | Category | Home

This article originally posted 08 February, 2012 and appeared in  Medication, Issue 612

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control

Cardiovascular CE & CME Clinical Slides Drugs Affecting BG Safety Tools Test Your Knowledge Medications Polls Obesity Case Studies Jobs Interviews GLP-1 Agonist Sheri R. Colberg, PhD SGLT-2

 

Free Weekly Newsletter
Sign up here.

Free CE Available
CE Programs on diabetes

Search Articles On Diabetes In Control